<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-05T20:28:29+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【2698】【中国好声音】国内多中心研究登顶JAMA子刊，评估高危HPV检测在中国宫颈癌筛查中的有效性</title>
    <updated>2021-01-05T20:01:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/v7sVGazLjJwE9dbCUUeCCg</id>
    <link href="https://mp.weixin.qq.com/s/v7sVGazLjJwE9dbCUUeCCg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020 SABCS】李俊杰教授：解读卵巢功能抑制最新进展，优化内分泌治疗</title>
    <updated>2021-01-05T20:01:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/AfXJ-AFbbbUvZfOAc2xg6g</id>
    <link href="https://mp.weixin.qq.com/s/AfXJ-AFbbbUvZfOAc2xg6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020 SABCS】精准化医疗在乳腺癌领域深入发展，RecurIndex®（28基因）助力N1患者术后放疗做“减法”</title>
    <updated>2021-01-05T20:01:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/LM0sN8E9y78Odu8Cxi3iWw</id>
    <link href="https://mp.weixin.qq.com/s/LM0sN8E9y78Odu8Cxi3iWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“隔离闷死病毒，学习看活研究” | 【13】中国抗癌协会乳腺癌诊治指南与规范（2019年版） 绝经前激素受体阳性患者治疗策略解读</title>
    <updated>2021-01-05T20:01:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/bWJbQn1yBMEYfMl5hSqN7A</id>
    <link href="https://mp.weixin.qq.com/s/bWJbQn1yBMEYfMl5hSqN7A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021 Best of SABCS 深圳——送你一朵小红花，一起讨论如何治疗乳腺癌</title>
    <updated>2021-01-05T20:01:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/y1c7FiY6RU5plf5_stJHvw</id>
    <link href="https://mp.weixin.qq.com/s/y1c7FiY6RU5plf5_stJHvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【倒计时5天】2021骨健康论坛——精准强效、多维获益</title>
    <updated>2021-01-05T20:01:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/ptAT4mf6ELP6NQFZIwqFlw</id>
    <link href="https://mp.weixin.qq.com/s/ptAT4mf6ELP6NQFZIwqFlw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【预告】2021北京泌尿肿瘤青年论坛暨泌尿肿瘤年终盘点——年度盛会，不容错过！</title>
    <updated>2021-01-05T20:01:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/uHWrxohJZSMWeg61hzoQOw</id>
    <link href="https://mp.weixin.qq.com/s/uHWrxohJZSMWeg61hzoQOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>安心可及，达济天下：等效优质广覆盖多瘤种患者 ——我国首款贝伐珠单抗生物类似药安可达®上市一周年</title>
    <updated>2021-01-04T19:13:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/HYLifbUPIxC837sQbuRkEQ</id>
    <link href="https://mp.weixin.qq.com/s/HYLifbUPIxC837sQbuRkEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>人物专访 丨礼来中国副总裁钱江：以学术为导向，深入挖掘市场尚未被满足的临床需求</title>
    <updated>2021-01-04T19:13:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/DsZO972O-ka8x6kzRu9OSw</id>
    <link href="https://mp.weixin.qq.com/s/DsZO972O-ka8x6kzRu9OSw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【左临右理】郭晔教授&amp;李江教授：临床与病理携手对话，解码头颈部鳞癌免疫治疗</title>
    <updated>2021-01-04T19:13:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/dEKeBL4U4UjjBwMrgVNqZw</id>
    <link href="https://mp.weixin.qq.com/s/dEKeBL4U4UjjBwMrgVNqZw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>如约而至——2021 Best of SABCS 深圳，与您不见不散</title>
    <updated>2021-01-04T19:13:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/AF6x_BnVm24ZCOnejFLO0w</id>
    <link href="https://mp.weixin.qq.com/s/AF6x_BnVm24ZCOnejFLO0w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MDT诊疗下，直肠癌合并同时性肝转移患者，如何取得总生存期的进一步突破？</title>
    <updated>2021-01-04T19:13:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-04:/s/GK5-RZ-4i9rleQ3eaMqy_A</id>
    <link href="https://mp.weixin.qq.com/s/GK5-RZ-4i9rleQ3eaMqy_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2696】【2020金研奖】徐建明教授：国内临床研究格局已翻天覆地，期待更多原创性研究</title>
    <updated>2021-01-03T19:25:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/JBtNIRSmeVc0vFFdMKavVQ</id>
    <link href="https://mp.weixin.qq.com/s/JBtNIRSmeVc0vFFdMKavVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【柳叶刀】KEYNOTE-355研究：Ⅲ期临床显示帕博利珠单抗联合化疗增强三阴性乳腺癌患者生存获益</title>
    <updated>2021-01-03T19:25:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/wLbJaStJV8Ol-oew292DqA</id>
    <link href="https://mp.weixin.qq.com/s/wLbJaStJV8Ol-oew292DqA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“隔离闷死病毒，学习看活研究” | 【12】2019版CSCO乳腺癌诊疗指南 绝经前激素受体阳性患者的治疗策略解读</title>
    <updated>2021-01-03T19:25:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-03:/s/f8salWgbQQwLLG7fNwvzoQ</id>
    <link href="https://mp.weixin.qq.com/s/f8salWgbQQwLLG7fNwvzoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2695】【Nature Research】中山大学孙逸仙纪念医院：中国西医先行者，引领抗击乳腺癌前沿</title>
    <updated>2021-01-02T17:35:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/QLmOb4wOmDmfzAIvtafF-Q</id>
    <link href="https://mp.weixin.qq.com/s/QLmOb4wOmDmfzAIvtafF-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【说文解泌】2020年度盘点|泌尿系肿瘤免疫治疗进展年度盘点</title>
    <updated>2021-01-02T17:35:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/uQXjdXpQ0KqXwl_izf63tg</id>
    <link href="https://mp.weixin.qq.com/s/uQXjdXpQ0KqXwl_izf63tg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【JCO】DARPin一类候选新药：VEGF/HGF抑制剂MP0250首次人体实体瘤应用</title>
    <updated>2021-01-02T17:35:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/vLDa76PO42SEqqLL21Q4mw</id>
    <link href="https://mp.weixin.qq.com/s/vLDa76PO42SEqqLL21Q4mw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【速递】阿帕替尼获批新适应证，肝细胞癌靶向治疗再添利器！</title>
    <updated>2021-01-02T17:35:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-02:/s/KRVi90_k7dc0sxe1Cepnrw</id>
    <link href="https://mp.weixin.qq.com/s/KRVi90_k7dc0sxe1Cepnrw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2694】2020 IASLC WCLC大幕即将拉开，大会主席吴一龙教授邀您来参会啦！</title>
    <updated>2021-01-01T19:00:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/candPOVrf80ovbfLsE_DPw</id>
    <link href="https://mp.weixin.qq.com/s/candPOVrf80ovbfLsE_DPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>